Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

217.72

VWAP

217.3

Open

217.82

Close

223.85

High

214.24

Low

301.65

52 Week High

221.61 ⇧
3.79 (1.74%)

JAGSNPHARM

(PHARMA)
45.4% Momentum

Turnaround Potential

155

52 Week Low

6.53

EPS

50.63

PE

5.29

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 221.61, this results in a dividend yield of 1.8 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 6.53. NSE:JAGSNPHARM book value per share as of today is 41.86. The current price to book ratio for JAGSNPHARM as of Jul 26, 2026 is 5.29.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 36.28% is very crucial parameter which shows that 36.28% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 217.72.

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #1321:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (Jul 26, 2026)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Up by 1.74% from its previous close of Rs 217.82. JAGSNPHARM stock last traded price is 221.61. JAGSNPHARM share price trend is Up with a total of 35039 stocks traded till now. It has touched an intraday high of Rs 223.85 and an intraday low of Rs 214.24. The JAGSNPHARM trading at 221.61, Up by Rs. 3.79, or 1.74 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Up.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Up by 1.74%. JAGSNPHARM share price short term trend is Up. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 217.72 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 221.61

JAGSNPHARM Share Price Target Prediction for 2026 ^

 162.5 - 242.6

JAGSNPHARM Share Price Target Prediction for 2027*^

 242.6 - 322.9

JAGSNPHARM Share Price Target Prediction for 2028*^

 322.9 - 345.5

JAGSNPHARM Share Price Target Prediction for 2029*^

 363

JAGSNPHARM Share Price Target Prediction for 2030*^

 373

JAGSNPHARM Share Price Target Prediction for 2035*^

 407
JAGSNPHARM Current Book Value 2025
41.7

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @232.77

JAGSNPHARM Moving Averages

BUY (11) NEUTRAL (0) SELL (3)
MA Simple Action S1 Expo Action E2
MA_5 233.81 SELL 233.06 SELL
MA_12 233.26 SELL 230.47 BUY
MA_20 226.04 BUY 226.82 BUY
MA_32 217.25 BUY 220.81 BUY
MA_50 214.44 BUY 215.65 BUY
MA_100 201.92 BUY 208.42 BUY
MA_200 201.02 BUY 205.78 BUY

JAGSNPHARM Trend Oscillators

BUY (3) NEUTRAL (0) SELL (1)
Trend Oscillators Value Action
Bollinger Bands 226.04 Uptrend
MACD -0.27 SELL
ADX 34.53 Strong Trend
DMI (+/-) 23.37 / 11.17 Uptrend

JAGSNPHARM Momentum Oscillators

BUY (3) NEUTRAL (7) SELL (2)
Momentum Oscillators Value Action
RSI 60.02 Neutral
STOCHASTIC_K (Fast) 28.35 Neutral
STOCHASTIC_D (Slow) 22.44 Neutral
CCI 11.57 Neutral
PSAR 257.79 SELL
TRUE RANGE 8.9 BUY
ATR 11.13 BUY
WILLIAMS R -60.76 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 25.32 Neutral
STOCHASTIC RSI D 15.05 Oversold
MOMENTUM 28.24 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 1.29%
3 Months 22.14%
1 Month 13.81%
1 Week -1.63%

JAGSNPHARM Technical Analysis Summary

Updated on 2026-07-10
Action Overall (%)
BUY 57%
NEUTRAL / HOLD 23%
SELL 20%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 221.61. JAGSNPHARM share price moved Up by 1.74% from its previous close of Rs 217.82.

Jagsonpal Pharmaceuticals Limited share price trend is Up with a total of 35039 stocks traded till now. It has touched an intraday high of Rs 304.6665 and an intraday low of Rs 214.24. The JAGSNPHARM trading at 221.61, Up by Rs. 3.79, or 1.74 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Up and the Stop Loss will be around 217.72.

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Jul 25, 2026.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Jul 25, 2026 is 50.63.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Jul 25, 2026 is 5.29.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹301.65 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹155 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹221.61, Up by Rs. 3.79, or 1.74 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Up.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹162.5 on downside and ₹242.6 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹242.6 on downside and ₹322.9 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹322.9 on downside and ₹345.5 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹373 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by 1.74%. The short-term trend for JAGSNPHARM share price is Up. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 217.72 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 78.3. Compared to the current market price of 221.61 INR, the JAGSNPHARM stock is Overvalued by 64.7%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 6.53. Jagsonpal Pharmaceuticals Limited book value per share as of today is 41.86. The current price to book ratio for JAGSNPHARM as of Jul 26, 2026 is 5.29.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1941.10 10.97 93.24
DIVISLAB 7248.50 98.2 629.49
MEDICAMEQ 241.85 6.94 206.22
CIPLA 1410.60 43.51 423.36
DRREDDY 1151.70 7.95 375.78
PGHH 5215.00 189.8 373.34
TORNTPHARM 4961.50 57.63 222.76
BIOCON 433.65 0.23 166.19
LUPIN 2370.50 139.24 659.04
ALKEM 5633.50 190.87 1170.81
Updated at: 24 Jul 2026 15:47

Feel free to contact us, in case of any queries.

SITEMAP 1331
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 3026.40 16.40 (0.54%) | ADANIGREEN 1395.10 15.20 (1.1%) | ADANIPORTS 1768.30 -10.20 (-0.57%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 425.15 1.60 (0.38%) | APOLLOHOSP 8805.50 -56.50 (-0.64%) | ASIANPAINT 2637.90 -30.90 (-1.16%) | ATGL 652.85 -9.75 (-1.47%) | AUROPHARMA 1532.00 8.60 (0.56%) | AXISBANK 1227.30 4.30 (0.35%) | BAJAJ-AUTO 11130.00 -153.50 (-1.36%) | BAJAJFINSV 1876.70 -12.70 (-0.67%) | BAJFINANCE 1012.80 -27.00 (-2.6%) | BALKRISIND 2013.50 2.10 (0.1%) | BANDHANBNK 165.93 0.09 (0.05%) | BANKBARODA 246.45 3.30 (1.36%) | BEL 405.00 -0.35 (-0.09%) | BERGEPAINT 497.95 4.35 (0.88%) | BHARTIARTL 1898.20 -32.80 (-1.7%) | BIOCON 433.65 -1.55 (-0.36%) | BOSCHLTD 41755.00 -485.00 (-1.15%) | BPCL 310.15 0.30 (0.1%) | BRITANNIA 5379.50 -8.50 (-0.16%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1410.60 17.60 (1.26%) | COALINDIA 427.40 0.35 (0.08%) | COLPAL 2086.10 0.30 (0.01%) | DABUR 423.20 0.05 (0.01%) | DIVISLAB 7248.50 -56.50 (-0.77%) | DLF 645.20 3.00 (0.47%) | DMART 4018.80 -16.20 (-0.4%) | DRREDDY 1151.70 -14.60 (-1.25%) | EICHERMOT 7628.00 -93.50 (-1.21%) | GAIL 170.02 -1.97 (-1.15%) | GLAND 2379.80 2.10 (0.09%) | GODREJCP 1059.50 0.90 (0.09%) | GRASIM 3089.40 -23.60 (-0.76%) | GUJGASLTD 327.05 -8.25 (-2.46%) | HAVELLS 1226.90 17.00 (1.41%) | HCLTECH 1271.00 26.30 (2.11%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2505.70 -3.00 (-0.12%) | HDFCBANK 742.80 -4.45 (-0.6%) | HDFCLIFE 555.05 4.10 (0.74%) | HEROMOTOCO 5011.10 -162.70 (-3.14%) | HINDALCO 942.80 -12.85 (-1.34%) | HINDUNILVR 2145.00 -16.80 (-0.78%) | HINDZINC 531.95 0.80 (0.15%) | ICICIBANK 1432.90 -1.70 (-0.12%) | ICICIGI 1661.80 42.80 (2.64%) | ICICIPRULI 500.55 -0.95 (-0.19%) | INDIGO 4985.00 -38.50 (-0.77%) | INDUSINDBK 996.05 -9.45 (-0.94%) | INDUSTOWER 394.60 4.35 (1.11%) | INFY 1040.90 -6.50 (-0.62%) | IOB 33.88 0.06 (0.18%) | IOC 138.47 -1.45 (-1.04%) | ITC 283.45 2.15 (0.76%) | JSWSTEEL 1240.80 -6.00 (-0.48%) | KOTAKBANK 384.75 1.40 (0.37%) | LT 3785.60 -6.80 (-0.18%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2370.50 -25.80 (-1.08%) | M&M 3161.40 -68.30 (-2.11%) | MARICO 855.60 2.40 (0.28%) | MARUTI 13442.00 39.00 (0.29%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 2986.70 -23.70 (-0.79%) | NAUKRI 1165.50 -4.45 (-0.38%) | NESTLEIND 1443.50 -4.40 (-0.3%) | NMDC 83.56 0.92 (1.11%) | NTPC 347.20 -1.40 (-0.4%) | ONGC 248.76 -3.61 (-1.43%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1570.90 6.70 (0.43%) | PIIND 2731.20 -11.40 (-0.42%) | PNB 110.38 0.23 (0.21%) | POWERGRID 288.20 -1.60 (-0.55%) | RELIANCE 1278.00 5.80 (0.46%) | SAIL 161.45 0.54 (0.34%) | SBICARD 618.75 -3.30 (-0.53%) | SBILIFE 1858.60 5.10 (0.28%) | SBIN 1015.00 2.40 (0.24%) | SHREECEM 26740.00 -85.00 (-0.32%) | SIEMENS 3689.80 3.50 (0.09%) | SRF 2664.70 42.00 (1.6%) | SUNPHARMA 1941.10 -12.90 (-0.66%) | TATACONSUM 1088.00 -19.70 (-1.78%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 182.67 -1.56 (-0.85%) | TCS 2254.30 11.40 (0.51%) | TECHM 1559.50 3.70 (0.24%) | TITAN 4677.00 -20.30 (-0.43%) | TORNTPHARM 4961.50 -103.70 (-2.05%) | ULTRACEMCO 11846.00 -62.00 (-0.52%) | UPL 602.45 -4.55 (-0.75%) | VEDL 264.65 0.05 (0.02%) | WIPRO 177.12 2.30 (1.32%) |